Advertisement

Why PCFP Is About To Dominate The Cannabis Market

An industry that's exploding like no other and a company set to be the profit-making, king of it all - that's the opportunity we have in front of us today.

Few industries have seen a growth rate like that of the cannabis industry in recent years. With the legalization of recreational marijuana use across several states in the US and across all of Canada in 2018, the entire industry is booming. That's not to mention the medical marijuana industry which is sizeable and ever-expanding in scope.

The challenge for investors looking to take advantage of this fact is that it seems to be a crowded market, and finding a dark horse that inspires confidence is easier said than done. That's why you should be very interested in the secret I'm about to share with you today: Apotheca Biosciences (PCFP) is that dark horse, and we have the research to back it up. 

​An Industry In The Midst Of Huge Growth

I know you want to hear all about Apotheca Biosciences, and I'll get to that, but first, it's important to talk about the immensely profitable industry they're in.


We're in the dawn of a new era when it comes to cannabis. What was once highly discredited and disallowed has worked its way into the spotlight, and medical experts have discovered a significant amount of practical uses for cannabis.


Ultimately, the proof is in the numbers. What was a 1.6 billion dollar industry in the US in 2013 has blossomed into a 3.8 billion dollar industry in 2018. That number is expected to nearly double by 2021 with an estimated 7 billion dollars of revenue coming from medical marijuana sales in the United States. Worldwide, the legal cannabis industry is expected to hit $57 billion by 2027.


That rate of industry growth is unprecedented, and it puts investors in a rare and fortuitous situation. If you pick the right company to invest in, you can ride that growth all the way to the top for massive profits.


This is an incredible opportunity, and we believe that Apotheca Biosciences is the company that will win the medical marijuana arms race.

The Company With The Edge To Win The Market


​Successful companies have an eye for the future and see where the market is heading, and that's why we have the utmost confidence that Apotheca Biosciences is the company to bet on in the medical marijuana space.


With their three medical products, CannaRAPID, CannaNASAL, and CannaDERME, they've upped the standard of what a cannabis-based product can do. Other companies have struggled to implement precise dosing and an effective delivery method, but Apotheca has risen to meet that challenge and has done extensive research and development to come up with ground-breaking new technology.


Their commitment to R&D is evident, and it's lead to breakthroughs like their sublingual, nasal, and transdermal delivery methods. That's one of the reasons their products are so effective and stand apart from the competition.


The health issues that Apotheca Biosciences is taking on are substantial - they include conditions like chronic pain, opioid addiction, dermatitis, acne, anxiety, migraines, and more. Apothica is confident in their solutions to each of these problems, and the answers to those significant problems come with big profits for the company behind them.


Beyond everything I've already mentioned, Apotheca has more exciting developments in the works that are set to rocket their stock upwards in the next 90 days, and every investor needs to know about it. 

​The ​ Right People Are In Place

The right personnel makes all the difference when it comes to standing out from the competition, and Apotheca was founded by some of the best in the industry while acquiring other critical talents along the way.

Apotheca is lead by Bobban Subhadra, a brilliant mind that believes industry disruption is one of the biggest differentiators between companies. With a Ph.D. in biomedical sciences and a masters in biology, Subhadra is the right man to be leading the company along with John Verghese and Deidre Fernandes.

With this executive team, it's easy to feel confident that the ship is being steered in the right direction, and that's made even more evident with the recent news of Apotheca's big move. 

​​Game-Changing Merger That Makes Apotheca A Powerhouse



​Apotheca already had the right parts to make them a contender in the medical marijuana space, but their recent merger with Cannabis Leaf Inc. will turn them from contender to champion.

Cannabis Leaf Inc. has been doing cutting-edge work in nutraceuticals, medical products, and delivery and formulation technologies in the consumer care and healthcare space. That breadth of experience will match perfectly with Apotheca's expertise in the space, and the combination both companies' assets make them a powerhouse.

This deal was only just announced, and it's one of the reasons that we're incredibly confident that Apotheca Biosciences' stock price will see a huge surge in the next two to three months. The market tends to react when massive mergers like this close, so when the Apothica and Cannabis Leaf Inc. merger is completed, you can expect to see a large uptick in Apotheca's share prices. 


​Putting It All Together

​​If ​ you've been looking for the right play in the marijuana industry, rest assured, this is the one. The industry is rife with potential, and Apotheca Biosciences has put everything together to dominate the space.

Evaluate the company for yourself before you make a move, but I urge you not to wait too long. The second this merger reaches completion, and the value gets priced into the stock, it will be too late to ride the upswing. We all know the feeling of getting into stock too late, so don't let that be the case with PCFP.

The cannabis industry is a hugely profitable one, and we have full confidence that Apotheca Biosciences is the vehicle through which investors can experience their profits.


Find out more information about company here.


© Daily Stock Picks - All Rights Reserved.      Disclaimer   |   Privacy   |    Contact

THIS IS AN ADVERTISEMENT AND NOT AN ACTUAL NEWS ARTICLE, BLOG, OR CONSUMER PROTECTION UPDATE

MARKETING DISCLOSURE: This website is a market place. As such you should know that the owner has a monetary connection to the product and services advertised on the site. The owner receives payment whenever a qualified lead is referred but that is the extent of it.